Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients.

European journal of radiology - 1 Sept 2013

Mann R M, Bult P, van Laarhoven H W M, Span P N, Schlooz M, Veltman J, Hoogerbrugge N

Abstract excerpt

OBJECTIVE: To assess the value of breast MRI in size assessment of breast cancers in high risk patients, including those with a BRCA 1 or 2 mutation. Guidelines recommend invariably breast MRI screening for these patients and therapy is thus based on these findings. However, the accuracy of breast MRI for staging purposes is only tested in sporadic cancers. METHODS: We assessed concordance of radiologic staging...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Magnetic Resonance Imaging

Share to Neoplasm Staging

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Tumor Burden

Source

Identifiers

PMID: 23567481
DOI: 10.1016/j.ejrad.2013.03.003

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients.PMID 23567481Read ↗

The clinicopathological and MRI features of patients with BRCA1/2 mutations in familial breast cancerSemantic proximity Read ↗

Improved characterization of sub-centimeter enhancing breast masses on MRI with radiomics and machine learning in BRCA mutation carriers.Semantic proximity Read ↗

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.Semantic proximity Read ↗

Characteristics, treatment, and outcome of breast cancers diagnosed in BRCA1 and BRCA2 gene mutation carriers in intensive screening programs including magnetic resonance imaging.Semantic proximity Read ↗

Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience.Semantic proximity Read ↗

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI.Semantic proximity Read ↗

MRI for breast cancer screening, diagnosis, and treatment.Semantic proximity Read ↗

Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.Semantic proximity Read ↗

Management of women at high risk for breast cancer: new imaging beyond mammography.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

Update on screening breast MRI in high-risk women.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.